Issue 5/2014
Content (10 Articles)
Benefit–Risk Assessment of Dabigatran in the Treatment of Stroke Prevention in Non-Valvular Atrial Fibrillation
Sascha Meyer dos Santos, Sebastian Harder
Comparative Safety and Efficacy of Proton Pump Inhibitors in Paediatric Gastroesophageal Reflux Disease
Jaroslaw Kierkus, Grzegorz Oracz, Bartosz Korczowski, Edyta Szymanska, Anna Wiernicka, Marek Woynarowski
Impact of Interventions Designed to Reduce Medication Administration Errors in Hospitals: A Systematic Review
Richard N. Keers, Steven D. Williams, Jonathan Cooke, Tanya Walsh, Darren M. Ashcroft
Digital Drug Safety Surveillance: Monitoring Pharmaceutical Products in Twitter
Clark C. Freifeld, John S. Brownstein, Christopher M. Menone, Wenjie Bao, Ross Filice, Taha Kass-Hout, Nabarun Dasgupta
A Comparison of the Effects of Different Typographical Methods on the Recognizability of Printed Drug Names
Calvin K. L. Or, Hailiang Wang
Fibrates and Risk of Cancer in Tissues with High PPAR-α Concentration: A Nested Case–Control Study
Francesco Salvo, Fabienne Bazin, Aude Kostrzewa, Christian Bandre, Philip Robinson, Nicholas Moore, Bernard Bégaud, Antoine Pariente
Adherence to Renal Function Monitoring Guidelines in Patients Starting Antihypertensive Therapy with Diuretics and RAAS Inhibitors: A Retrospective Cohort Study
Jan C. van Blijderveen, Sabine M. Straus, Maria A. de Ridder, Bruno H. Stricker, Miriam C. Sturkenboom, Katia M. Verhamme
Erratum to: Dose-Specific Adverse Drug Reaction Identification in Electronic Patient Records: Temporal Data Mining in an Inpatient Psychiatric Population
Robert Eriksson, Thomas Werge, Lars Juhl Jensen, Søren Brunak
Erratum to: The Weber Effect and the United States Food and Drug Administration’s Adverse Event Reporting System (FAERS): Analysis of Sixty-Two Drugs Approved from 2006 to 2010
Keith B. Hoffman, Mo Dimbil, Colin B. Erdman, Nicholas P. Tatonetti, Brian M. Overstreet